Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TUBB4AP1 is a human pseudogene located on chromosome X (GRCh37:CM000685.1), spanning positions 122,695,493–122,696,817 on the forward strand. Pseudogenes like TUBB4AP1 typically result from gene duplication or retrotransposition events during genome evolution and do not encode functional proteins. TUBB4AP1 shares sequence similarity with protein-coding tubulin beta genes but lacks regulatory and/or coding elements necessary for expression and function. There are no known biological functions, disease associations, or therapeutic implications for TUBB4AP1. It is classified strictly as a pseudogene; any therapeutic utility or drug targeting is not supported by scientific evidence. TUBB4AP1 should not be confused with active tubulin beta protein-coding genes (such as TUBB4A), which play essential roles in microtubule structure and are sometimes considered drug targets (e.g., for anti-microtubule agents in cancer therapy). Pseudogenes are not typically included in therapeutic target lists unless emerging evidence shows regulatory function, which is not the case for TUBB4AP1.
Null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin beta 4A class IVa pseudogene 1 (TUBB4AP1).